Nyla is a Clinical Trial Manager, responsible for the set-up and oversight of medical technology studies.
She is currently setting up the PETRUSHKA study led by Professor Andrea Cipriani, which aims to evaluate a novel decision-making tool which will be used to aid clinicians in prescribing antidepressants. Prior to joining OBHCTU, Nyla worked within the Translational Neuroscience and Dementia Research Group setting up and managing multi-centre clinical trials and observational studies in Alzheimer's disease and Mild Cognitive Impairment (MCI). Previous to this, Nyla worked as a Clinical Trial Coordinator within an NHS setting. She was involved in several phase I-III clinical trials investigating novel disease modifying therapies in patients with Alzheimer’s disease. Within her time at the Neuroepidemology & Ageing Unit, Imperial College London, she gained experience of coordinating a large prospective readiness cohort study investigating risk factors of Alzheimer’s disease in healthy participants. During her BSc Psychology degree, Nyla spent her university placement year working in a neurorehabilitation service for adults who had suffered traumatic & acute brain injury.